Emergency Stroke Management. A New Era

Nursing Clinics of North America

Volumn 37, Issue 1, 2002, Pages 35-57

  Carrozzella, Janice ^a,b   Jauch, Edward C ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b The Greater Cincinnati/Northern Kentucky Stroke Team ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ALGORITHM; CEREBROVASCULAR ACCIDENT; CLASSIFICATION; DECISION TREE; DIFFERENTIAL DIAGNOSIS; EMERGENCY HEALTH SERVICE; EMERGENCY TREATMENT; HEALTH CARE; HEALTH CARE QUALITY; HEALTH EDUCATION; HOSPITALIZATION; HUMAN; INFORMATION SERVICE; INTERNET; METHODOLOGY; NURSING; PATIENT SELECTION; REVIEW; RISK FACTOR; SURVIVAL; TIME; UNITED STATES;

ALGORITHMS; CEREBROVASCULAR ACCIDENT; COMPREHENSIVE HEALTH CARE; DECISION TREES; DIAGNOSIS, DIFFERENTIAL; EMERGENCY MEDICAL SERVICES; EMERGENCY TREATMENT; FIBRINOLYTIC AGENTS; HEALTH EDUCATION; HOSPITALIZATION; HUMANS; INFORMATION SERVICES; INTERNET; PATIENT SELECTION; QUALITY OF HEALTH CARE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; UNITED STATES;

EID: 0036514089     PISSN: 00296465     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-6465(03)00081-1     Document Type: Review

References (27)

1. Adams Jr. H.P., Davis P.H., Leira E.C., et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 53 (1999) 126-131
2. Adams Jr. H.P., Brott T.G., Furlan A.J., et al. Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 94 (1996) 1167-1174
3. Albers G.W., Bates V.E., and Clark W.M. Intravenous tissue-type plasminogen activator for treatment of acute stroke: The Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 283 (2000) 1145-1150
4. Alberts M.J., Hademenos G., and Latchaw R.E. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA 283 (2000) 3102-3109
5. American Heart Association: Textbook of Advanced Cardiac Life Support, AHA, Dallas, Texas, 1997
6. Barsan W.G., Brott T., Broderick J., et al. Time of hospital presentation in patients with acute stroke. Arch Intern Med 153 (1993) 2558-2561
7. Bonita R., and Beaglehole R. The enigma of the decline in stroke deaths in the United States: The search for an explanation. Stroke 27 (1996) 370-372
8. Broderick J., Brott T., Kothari R., et al. The Greater Cincinnati/Northern Kentucky Stroke Study: Preliminary first-ever and total incidence rates of stroke among blacks. Stroke 29 (1998) 415-421
9. Brott T.G., Clark W.M., and Fagan S.C. Stroke: The First Hours. Guidelines for Acute Treatment (2000), National Stroke Association, Englewood, Colorado
10. CAST investigators. Randomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 349 (1997) 1641-1649
11. Chen Z.M., Sandercock P., and Pan H.C. Indications for early aspirin use in acute ischemic stroke: A combined analysis of 40,000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. On behalf of the CAST and IST collaborative groups. Stroke 31 (2000) 1240-1249
12. Cohen S. Management of Ischemic Stroke (2000), McGraw-Hill, New York
13. Foulkes M.A., Wolf P.A., Price T.R., et al. The Stroke Data Bank: Design, methods, and baseline characteristics. Stroke 19 (1988) 547-554
14. Gawronski D.W., and Reding M.J. Post-stroke depression: An update. Current Atherosclerosis Reports 3 (2001) 307-312
15. Ginsberg MD, Bogousslavsky J: Cerebrovascular Disease. Cambridge, MA, Blackwell Scientific, Maldow, Massachusetts, 1998
16. Hacke W., Kaste M., and Fieschi C. Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 352 (1998) 1245-1251
17. Jorgensen H.S., Nakayama H., Raaschou H.O., et al. The effect of a stroke unit: Reductions in mortality, discharge rate to nursing home, length of hospital stay, and cost. A community-based study. Stroke 26 (1995) 1178-1182
18. Katzan I.L., Furlan A.J., and Lloyd L.E. Use of tissue-type plasminogen activator for acute ischemic stroke: The Cleveland area experience. JAMA 283 (2000) 1151-1158
19. Kidwell C.S., Saver J.L., Schubert G.B., et al. Design and retrospective analysis of the Los Angeles Prehospital Stroke Screen (LAPSS). Prehospital Emergency Care 2 (1998) 267-273
20. Kothari R.U., Jauch E.C., and Broderick J. Acute stroke: Delays to presentation and emergency department evaluation. Ann Emerg Med 33 (1999) 3-8
21. Kothari R.U., Pancioli A., and Liu T. Cincinnati Prehospital Stroke Scale: Reproducibility and validity. Ann Emerg Med 33 (1999) 373-378
22. Lewandowski C.A., Frankel M., Tomsick T.A., et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 30 (1999) 2598-2605
23. Lyden P., Brott T., and Tilley B. Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke 25 (1994) 2220-2226
24. Marler JR, Emr M, Jones P: Proceedings of a National Symposium on Rapid Identification and Treatment of Acute Stroke. NIH Publication 97-4239. Bethesda, MD, National Institute of Neurological and Disorders and Stroke, 1997
25. National Institute of Neurological Disorders and Stroke rt-PA StrokeStudy Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995) 1581-1587
26. Pancioli A.M., Broderick J., Kothari R., et al. Public perception of stroke warning signs and knowledge of potential risk factors. JAMA 279 (1998) 1288-1292
27. Wentworth D.A., and Atkinson R.P. Implementation of an acute stroke program decreases hospitalization costs and length of stay. Stroke 27 (1996) 1040-1043